US 8357783
Human anti-mesothelin monoclonal antibodies
granted A61PA61P35/00A61P35/04
Quick answer
US patent 8357783 (Human anti-mesothelin monoclonal antibodies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P35/00, A61P35/04